Pawel K Mazur, PhD

Affiliations: 
2005-2011 Max Planck Institut for Medical Research/Technical University of Munich 
 2011-2016 Stanford University, Palo Alto, CA 
 2016- Experimental Radiation Oncology The University of Texas MD Anderson Cancer Center 
Website:
https://faculty.mdanderson.org/profiles/pawel_mazur.html
Google:
"Pawel Mazur"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lukinovic V, Hausmann S, Roth GS, et al. (2022) SMYD3 impedes small cell lung cancer sensitivity to alkylation damage through RNF113A methylation-phosphorylation crosstalk. Cancer Discovery
Sengupta D, Zeng L, Li Y, et al. (2021) NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesis. Molecular Cell
Hester R, Mazur PK, McAllister F. (2021) Immunotherapy in Pancreatic Adenocarcinoma: Beyond "Copy / Paste". Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Yuan G, Flores NM, Hausmann S, et al. (2021) Elevated NSD3 histone methylation activity drives squamous cell lung cancer. Nature
Wang Z, Hausmann S, Lyu R, et al. (2020) SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. Cancer Cell
Valencia K, Erice O, Kostyrko K, et al. (2019) The mir181ab1 cluster promotes kras-driven oncogenesis and progression in lung and pancreas. The Journal of Clinical Investigation
Liu S, Hausmann S, Carlson SM, et al. (2018) METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis. Cell
Mello SS, Sinow C, Raj N, et al. (2017) Neat1 is a p53-inducible lincRNA essential for transformation suppression. Genes & Development
Vallejo A, Perurena N, Guruceaga E, et al. (2017) An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer. Nature Communications. 8: 14294
Mazur PK, Gozani O, Sage J, et al. (2016) Novel insights into the oncogenic function of the SMYD3 lysine methyltransferase. Translational Cancer Research. 5: 330-333
See more...